Ibrahim HalilSahinMD

PubMed

• Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future.
  Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, Vikram Gorantla, John Rhree, Monica Malhotra, Roby Thomas, Dennis Hsu, Anwaar Saeed> ;JCO Oncology Practice. 2023 Mar 2
• Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer.
  Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie> ;American Journal of Clinical Oncology. 2023 Feb 1
• 1 citations
  The benefit of immunotherapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
  Deniz Can Guven, Enes Erul, Taha Koray Sahin, Omer Dizdar, Suayib Yalcin, Ibrahim Halil Sahin> ;Future Oncology. 2022 Dec 19
• Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine.
  Ruveyda Ayasun, Turcin Saridogan, Ola Gaber, Ibrahim Halil Sahin> ;Clinical Colorectal Cancer. 2023 Mar 1
• 1 citations
  Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
  Rutika Mehta, Jessica Frakes, Jongphil Kim, Andrew Nixon, Yingmiao Liu, Lauren Howard, Maria E Martinez Jimenez, Estrella Carballido, Iman Imanirad, Julian Sanchez, So...> ;The Oncologist. 2022 Aug 5
• Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
  Samer A Naffouje, Nicholas Manguso, Iman Imanirad, Ibrahim H Sahin, Hao Xie, Sarah Hoffe, Jessica Frakes, Julian Sanchez, Sophie Dessureault, Seth Felder> ;Journal of Surgical Oncology. 2022 Dec 1
• 1 citations
  Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.
  Elaine S Tan, Wenyi Fan, Todd C Knepper, Michael J Schell, Ibrahim H Sahin, Jason B Fleming, Hao Xie> ;Targeted Oncology. 2022 Jul 1
• 11 citations
  A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.
  Richard D Kim, Bence P Kovari, Maria Martinez, Hao Xie, Ibrahim H Sahin, Rutika Mehta, Jonathan Strosberg, Iman Imanirad, Masoumeh Ghayouri, Young-Chul Kim, Dae Won Kim> ;European Journal of Cancer. 2022 Jul 1
• 2 citations
  Human Epidermal Growth Factor Receptor 2-Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues.
  Canan Karan, Elaine Tan, Humaira Sarfraz, Todd C Knepper, Christine M Walko, Seth Felder, Richard Kim, Ibrahim Halil Sahin> ;JCO Oncology Practice. 2022 Aug 1
• Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers.
  Elaine Tan, Junmin Whiting, Todd Knepper, Hao Xie, Iman Imanirad, Estrella Carballido, Seth Felder, Jessica Frakes, Qianxing Mo, Jennifer B Permuth, Katelyn Somerer, R...> ;American Journal of Clinical Oncology. 2022 Apr 1
• 4 citations
  Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues.
  Ibrahim Halil Sahin, Kristen K Ciombor, Luis A Diaz, James Yu, Richard Kim> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022 Apr 1
• BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer.
  Elaine Tan, Junmin Whiting, Hao Xie, Iman Imanirad, Estrella Carballido, Seth Felder, Jessica Frakes, Quanxing Mo, Christine Walko, Jennifer B Permuth, Katelyn Sommere...> ;The Oncologist. 2022 Mar 11
• New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
  Ibrahim Sahin, Hanife Saat> ;Genetic Testing and Molecular Biomarkers. 2022 Jan 1
• 3 citations
  Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA.
  Jinyong Huang, Alex C. Soupir, Brian D. Schlick, Mingxiang Teng, Ibrahim H. Sahin, Jennifer B. Permuth, Erin M. Siegel, Brandon J. Manley, Bruna Pellini, Liang Wang> ;Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft Für Gastroenterologie, Verdauungs- Und Stoffwechselkrankheiten. 2021 Nov 9
• Liquid biopsy: Novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors.
  Ibrahim Sahin, Hanife Saat, Sercan Aksoy, Omer Dizdar, Haktan Bağış Erdem, Taha Bahsi> ;Molecular and Clinical Oncology. 2021 Nov 3
• 2 citations
  High Expression of Stem Cell-Related Genes in Polyps with Villous Features and High-Grade Dysplasia Support Malignant Phenotype and Colorectal Carcinogenesis
  Ibrahim Sahin, Betul Gundogdu, Ahmet Cevdet Ceylan, Haktan Bağış Erdem, Abdulgani Tatar> ;Asian Pacific Journal of Cancer Prevention. 2021 Aug 1
• 1 citations
  A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2
  Ibrahim Sahin, Hanife Saat> ;Molecular Biology Reports. 2021 Jun 19
• 7 citations
  BRAF Mutations as Actionable Targets: A Paradigm Shift in the Management of Colorectal Cancer and Novel Avenues.
  Ibrahim Halil Sahin, Jim Klostergaard> ;JCO Oncology Practice. 2021 Jun 2
• 7 citations
  Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation.
  Alec Bigness, Iman Imanirad, Ibrahim Halil Sahin, Hao Xie, Jessica M. Frakes, Sarah E. Hoffe, Danielle Laskowitz, Seth Felder> ;CA. 2021 May 1
• 1 citations
  Regorafenib, an investigational agent for the treatment of cholangiocarcinoma.
  Ibrahim Halil Sahin, Elaine Tan, Richard Kim> ;Expert Opinion on Investigational Drugs. 2021 Apr 3
• 4 citations
  Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision.
  Samer Naffouje, Arvind Sabesan, Benjamin D. Powers, Sophie Dessureault, Julian Sanchez, Michael J. Schell, Iman Imanirad, Ibrahim Halil Sahin, Hao Xie, Seth Felder> ;Clinical Colorectal Cancer. 2021 Feb 27
• 6 citations
  Mismatch Repair (MMR) gene alteration and BRAF V600E mutation are potential predictive biomarkers of immune checkpoint inhibitors in MMR-deficient colorectal cancer
  Ibrahim Halil Sahin, Subir Goyal, Yoanna Pumpalova, Mohamad Bassam Sonbol, Satya Das, Sigurdis Haraldsdottir, Daniel H. Ahn, Kristen K. Ciombor, Zhengjia Chen, Amber D...> ;The Oncologist. 2021 Aug 1
• 11 citations
  Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding li...
  Elaine Tan, Ibrahim Halil Sahin> ;Expert Review of Gastroenterology & Hepatology. 2021 Feb 18
• 4 citations
  Neoadjuvant and adjuvant treatment approaches for hepatocellular carcinoma: future outlook.
  Ibrahim Halil Sahin, Lana Khalil, Ralph Millett, Ahmed Kaseb> ;Chinese clinical oncology. 2021 Jan 11
• 2 citations
  Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
  Gokce Askan, Ibrahim Halil Sahin, Joanne F. Chou, Aslihan Yavas, Marinela Capanu, Christine A. Iacobuzio-Donahue, Olca Basturk, Eileen M. O'Reilly> ;BMC Cancer. 2021 Apr 9
• Join now to see all